NanoVibronix, Inc. (NAOV)
USD 2.34
(0.86%)
USD 2.34
(0.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.67 Million USD | 13.52% |
| 2022 | 5.87 Million USD | -31.81% |
| 2021 | 8.62 Million USD | 4.78% |
| 2020 | 8.22 Million USD | 304.17% |
| 2019 | 2.03 Million USD | 28.86% |
| 2018 | 1.58 Million USD | -67.52% |
| 2017 | 4.86 Million USD | 884.82% |
| 2016 | 494 Thousand USD | -75.09% |
| 2015 | 1.98 Million USD | 174.27% |
| 2014 | 723 Thousand USD | 4.63% |
| 2013 | 691 Thousand USD | 97.99% |
| 2012 | 349 Thousand USD | -67.83% |
| 2011 | 1.08 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5.69 Million USD | -8.64% |
| 2024 Q1 | 6.23 Million USD | -6.58% |
| 2023 Q2 | 3.83 Million USD | -20.37% |
| 2023 FY | 6.67 Million USD | 13.52% |
| 2023 Q1 | 4.81 Million USD | -18.17% |
| 2023 Q4 | 6.67 Million USD | -9.33% |
| 2023 Q3 | 7.36 Million USD | 92.14% |
| 2022 Q1 | 7.66 Million USD | -11.12% |
| 2022 Q3 | 5.21 Million USD | -20.36% |
| 2022 Q4 | 5.87 Million USD | 12.84% |
| 2022 FY | 5.87 Million USD | -31.81% |
| 2022 Q2 | 6.54 Million USD | -14.63% |
| 2021 Q2 | 6.83 Million USD | -20.59% |
| 2021 Q1 | 8.6 Million USD | 4.54% |
| 2021 Q3 | 9.66 Million USD | 41.48% |
| 2021 FY | 8.62 Million USD | 4.78% |
| 2021 Q4 | 8.62 Million USD | -10.8% |
| 2020 Q4 | 8.22 Million USD | 100.61% |
| 2020 Q3 | 4.1 Million USD | 306.54% |
| 2020 FY | 8.22 Million USD | 304.17% |
| 2020 Q2 | 1 Million USD | -9.99% |
| 2020 Q1 | 1.12 Million USD | -44.94% |
| 2019 FY | 2.03 Million USD | 28.86% |
| 2019 Q1 | 817 Thousand USD | -48.29% |
| 2019 Q2 | 3.1 Million USD | 280.29% |
| 2019 Q3 | 3.07 Million USD | -1.19% |
| 2019 Q4 | 2.03 Million USD | -33.68% |
| 2018 Q2 | 3.17 Million USD | -20.18% |
| 2018 FY | 1.58 Million USD | -67.52% |
| 2018 Q3 | 2.42 Million USD | -23.57% |
| 2018 Q1 | 3.97 Million USD | -18.29% |
| 2018 Q4 | 1.58 Million USD | -34.85% |
| 2017 Q3 | 809 Thousand USD | 6.87% |
| 2017 Q2 | 757 Thousand USD | 69.73% |
| 2017 Q1 | 446 Thousand USD | -9.72% |
| 2017 FY | 4.86 Million USD | 884.82% |
| 2017 Q4 | 4.86 Million USD | 501.36% |
| 2016 FY | 494 Thousand USD | -75.09% |
| 2016 Q4 | 494 Thousand USD | -46.54% |
| 2016 Q3 | 924 Thousand USD | -25.3% |
| 2016 Q2 | 1.23 Million USD | -25.08% |
| 2016 Q1 | 1.65 Million USD | -16.74% |
| 2015 Q1 | 3.05 Million USD | 321.99% |
| 2015 Q3 | 2.35 Million USD | -10.5% |
| 2015 Q4 | 1.98 Million USD | -15.72% |
| 2015 FY | 1.98 Million USD | 174.27% |
| 2015 Q2 | 2.62 Million USD | -13.83% |
| 2014 Q3 | 844 Thousand USD | 0.0% |
| 2014 Q1 | 795 Thousand USD | 15.05% |
| 2014 Q4 | 723 Thousand USD | -14.34% |
| 2014 FY | 723 Thousand USD | 4.63% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q2 | 440 Thousand USD | 0.0% |
| 2013 Q3 | 435 Thousand USD | -1.14% |
| 2013 Q4 | 691 Thousand USD | 58.85% |
| 2013 FY | 691 Thousand USD | 97.99% |
| 2012 Q4 | 349 Thousand USD | 0.0% |
| 2012 FY | 349 Thousand USD | -67.83% |
| 2011 FY | 1.08 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 78.722% |
| BrainsWay Ltd. | 62.97 Million USD | 89.402% |
| Cerus Corporation | 197.74 Million USD | 96.625% |
| Envoy Medical, Inc. | 7.64 Million USD | 12.644% |
| electroCore, Inc. | 16.38 Million USD | 59.273% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | 13.235% |
| IceCure Medical Ltd | 16.41 Million USD | 59.33% |
| Inogen, Inc. | 326.19 Million USD | 97.954% |
| OrthoPediatrics Corp. | 449.58 Million USD | 98.516% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 75.526% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 59.744% |
| MaxCyte, Inc. | 268.27 Million USD | 97.512% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | 17.578% |
| Nexalin Technology, Inc. | 3.63 Million USD | -83.76% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.279% |
| PAVmed Inc | 33.11 Million USD | 79.848% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 95.348% |
| RxSight, Inc. | 182.55 Million USD | 96.344% |
| Sight Sciences, Inc. | 166.65 Million USD | 95.995% |
| SI-BONE, Inc. | 230.42 Million USD | 97.104% |
| TELA Bio, Inc. | 78.04 Million USD | 91.449% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 97.351% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 37.801% |
| Acutus Medical, Inc. | 53.96 Million USD | 87.632% |
| Talis Biomedical Corporation | 98.34 Million USD | 93.213% |
| Spectral AI, Inc. | 10.69 Million USD | 37.579% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 96.948% |
| CVRx, Inc. | 115.22 Million USD | 94.208% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 88.623% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -114.236% |
| Bioventus Inc. | 810.91 Million USD | 99.177% |
| Venus Concept Inc. | 93.65 Million USD | 92.874% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 74.056% |
| LivaNova PLC | 2.42 Billion USD | 99.725% |
| 908 Devices Inc. | 202.98 Million USD | 96.712% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 99.171% |
| Nemaura Medical Inc. | 14.56 Million USD | 54.172% |
| NeuroPace, Inc. | 107.65 Million USD | 93.8% |
| LENSAR, Inc. | 69.58 Million USD | 90.409% |
| Apyx Medical Corporation | 79.24 Million USD | 91.577% |
| Cutera, Inc. | 346.29 Million USD | 98.073% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 84.116% |
| BioSig Technologies, Inc. | 1.79 Million USD | -271.19% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 97.534% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 84.356% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.824% |
| Axonics, Inc. | 719.92 Million USD | 99.073% |
| Outset Medical, Inc. | 313.8 Million USD | 97.873% |
| IRIDEX Corporation | 34.43 Million USD | 80.619% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 98.351% |
| IRadimed Corporation | 92.15 Million USD | 92.758% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -27.027% |
| INVO Bioscience, Inc. | 20.88 Million USD | 68.048% |
| Telesis Bio, Inc. | 70.41 Million USD | 90.521% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 95.669% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.466% |
| Quipt Home Medical Corp. | 247.4 Million USD | 97.302% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 28.314% |
| Pulmonx Corporation | 178.95 Million USD | 96.27% |
| Dynatronics Corporation | 25.94 Million USD | 74.272% |
| Modular Medical, Inc. | 13.8 Million USD | 51.662% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 37.783% |
| Semler Scientific, Inc. | 78.06 Million USD | 91.451% |
| InMode Ltd. | 863.28 Million USD | 99.227% |
| Bruker Corporation | 4.24 Billion USD | 99.843% |
| Cytosorbents Corporation | 53.26 Million USD | 87.469% |
| DexCom, Inc. | 6.26 Billion USD | 99.893% |
| Align Technology, Inc. | 6.08 Billion USD | 99.89% |
| Viveve Medical, Inc. | 25.91 Million USD | 74.245% |
| ZimVie Inc. | 1.2 Billion USD | 99.446% |
| Movano Inc. | 9.42 Million USD | 29.158% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 98.659% |
| Nexalin Technology, Inc. | 3.63 Million USD | -83.76% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 88.623% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.299% |
| Profound Medical Corp. | 43.68 Million USD | 84.723% |
| Insulet Corporation | 2.58 Billion USD | 99.742% |
| enVVeno Medical Corporation | 48.63 Million USD | 86.277% |
| Surmodics, Inc. | 185.73 Million USD | 96.407% |
| iCAD, Inc. | 41.41 Million USD | 83.886% |
| Nuwellis, Inc. | 9.77 Million USD | 31.689% |
| Biotricity, Inc. | 5.94 Million USD | -12.307% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 98.459% |
| Aethlon Medical, Inc. | 8.24 Million USD | 19.064% |
| InspireMD, Inc. | 47.64 Million USD | 85.992% |
| PAVmed Inc. | 33.11 Million USD | 79.848% |
| BIOLASE, Inc. | 35.1 Million USD | 80.986% |
| Beyond Air, Inc. | 56.96 Million USD | 88.283% |
| FONAR Corporation | 214.24 Million USD | 96.885% |
| AxoGen, Inc. | 196.82 Million USD | 96.609% |
| Vivani Medical, Inc. | 45.79 Million USD | 85.427% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 97.629% |
| Inari Medical, Inc. | 674.23 Million USD | 99.01% |
| UFP Technologies, Inc. | 404.13 Million USD | 98.349% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 71.477% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 29.77% |
| Tenon Medical, Inc. | 6.34 Million USD | -5.185% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 29.053% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 93.561% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.856% |
| Sintx Technologies, Inc. | 15.36 Million USD | 56.564% |
| Quanterix Corporation | 425.01 Million USD | 98.43% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 28.314% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 87.578% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.618% |
| TransMedics Group, Inc. | 706.04 Million USD | 99.055% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 89.439% |
| NeuroMetrix, Inc. | 21.42 Million USD | 68.849% |
| Hyperfine, Inc. | 94.19 Million USD | 92.915% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 97.516% |
| Biomerica, Inc. | 9.25 Million USD | 27.88% |
| Bone Biologics Corporation | 3.73 Million USD | -78.556% |
| AVITA Medical, Inc. | 144.33 Million USD | 95.376% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -37.084% |
| Silk Road Medical, Inc | 265.3 Million USD | 97.484% |